British scientists halted a large trial on Friday that had been exploring the use of the anti-malaria drug hydroxychloroquine in patients with the pandemic disease Covid-19 after initial results showed no evidence of benefit.
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment